With help from Leah Nylen Editor’s Note: Morning Tech is a free version of POLITICO Pro Technology’s morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro. — Hitting pause: Google is heading to court this week in a bid to block “highly sensitive information” about its business from being revealed in… Source link

A new study on COVID-19 transmission done by researchers at Georgia Tech University and North Carolina State University paints a dire picture for students who go to school unmasked and unvaccinated. Model findings from the study found that in a 500-student school, an additional 70% of elementary school students may be infected with COVID-19 within three months without masks and 40% of elementary school students may be infected within three months with masks. Vaccinated middle and high schools… Source link

Google says it is ramping up its investments in health-focused initiatives even as it dissolves its single unified health division. From consumer-facing products like sleep tracking tech with its Nest Hub smart home devices and Fitbit wearables to clinical initiatives like its Care Studio EHR search tool and its health AI work, Google has intensified its focus on health tech and expanded its reach into the healthcare market. But those projects will now be split across Google’s myriad… Source link

Stock futures gained Monday morning, steadying after last week’s volatility as investors looked ahead to a key event from the Federal Reserve later this week. S&P 500 futures rose by more than 0.3%, led by gains in energy stocks as oil prices advanced. U.S. West Texas intermediate crude oil futures (CL=F) topped $64 a barrel, and Brent crude (BZ=F) jumped above $67 per barrel after suffering its longest losing streak since early 2018 as of last week.  Contracts on the Dow were set to open… Source link

(Adds details on Trillium’s drug candidates, share movement) Aug 23 (Reuters) – Pfizer Inc said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies. Pfizer, which acquired a $25 million stake in Trillium last year, will buy the remaining outstanding shares for $18.50 apiece, representing a 203.8% premium on the stock’s last closing price. Pfizer expects to benefit from Canada-based Trillium’s… Source link

Heading into a new trading week, Pfizer Inc. (NYSE: PFE), Alibaba Group Holding Limited (NYSE: BABA), Nvidia Corp. (NASDAQ: NVDA) and Moderna Inc. (NASDAQ: MRNA) are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum. What Happened: Pfizer has emerged as the most-discussed stock on the forum with 106 mentions, followed by exchange-traded fund SPDR S&P 500 ETF Trust (NYSE: SPY) with 102 mentions, data from Quiver Quantitative showed. Chinese e-commerce giant… Source link

This fall, if you aren’t rocking some form of wide leg jeans while also owning shares of Abercrombie & Fitch (ANF) and American Eagle Outfitters (AEO) in your portfolio you may be off trend in two areas of your life. Google searches for low-rise jeans have surged 91% over the past six months — with wide leg and flare jeans being the most popular styles — per fresh analysis from Jefferies retail analyst Stephanie Wissink. In other words, the 18-year reign of skinny jeans as the de facto… Source link

Suhail Shaheen, a Taliban spokesperson. Sergei SavostyanovTASS via Getty Images A Taliban spokesperson said that extending the US withdrawal deadline could provoke a “reaction.” The warning came after Biden said the US could extend its August 31 deadline to help the evacuation. Scenes of chaos and terror have unfolded at Kabul airport after the Taliban seized power. See more stories on Insider’s business page. A Taliban spokesperson warned of “consequences” if the US kept troops in Afghanistan… Source link

NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) informed the Company in a teleconference on August 20, 2021, that its review of the new drug application (NDA) for AXS-05 for the treatment of major depressive disorder would not be completed by the Prescription Drug User Fee… Source link

Some of the world’s most powerful central bankers will convene virtually this week, with the focus on any commentary suggesting a pullback in pandemic-era easy money policies from the Federal Reserve.  One challenge: the timeline for slowing the central bank’s $120-billion-a-month pace of asset purchases will be different depending on which Federal Open Market Committee member you ask. The divergence on the FOMC will draw attention to the Fed’s Jackson Hole meeting (which was again moved… Source link